β2* nAChR sensitivity modulates acquisition of cocaine self-administration in male rats. 2024

Noah B Walker, and Brenton R Tucker, and Leanne N Thomas, and Andrew E Tapp, and Anna I Neel, and Rong Chen, and Sara R Jones, and Ryan M Drenan
Department of Physiology & Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

Signaling through nicotinic acetylcholine receptors (nAChRs) plays a role in cocaine reward and reinforcement, suggesting that the cholinergic system could be manipulated with therapeutics to modulate aspects of cocaine use disorder (CUD). We examined the interaction between nAChRs and cocaine reinforcement by expressing a hypersensitive β2 nAChR subunit (β2Leu9'Ser) in the ventral tegmental area of male Sprague Dawley rats. Compared to control rats, β2Leu9'Ser rats acquired (fixed ratio) intravenous cocaine self-administration faster and with greater likelihood. By contrast, β2Leu9'Ser rats were approximately equivalent to controls in their intake of cocaine on a progressive ratio schedule of reinforcement, suggesting differential effects of cholinergic signaling depending on experimental parameters. Like progressive ratio cocaine SA, β2Leu9'Ser rats and controls did not differ significantly in food SA assays, including acquisition on a fixed ratio schedule or in progressive ratio sessions. These results highlight the specific role of high-affinity, heteropentameric β2* (β2-containing) nAChRs in acquisition of cocaine SA, suggesting that mesolimbic acetylcholine signaling is active during this process.

UI MeSH Term Description Entries

Related Publications

Noah B Walker, and Brenton R Tucker, and Leanne N Thomas, and Andrew E Tapp, and Anna I Neel, and Rong Chen, and Sara R Jones, and Ryan M Drenan
November 1995, Brain research,
Noah B Walker, and Brenton R Tucker, and Leanne N Thomas, and Andrew E Tapp, and Anna I Neel, and Rong Chen, and Sara R Jones, and Ryan M Drenan
February 2012, Psychopharmacology,
Noah B Walker, and Brenton R Tucker, and Leanne N Thomas, and Andrew E Tapp, and Anna I Neel, and Rong Chen, and Sara R Jones, and Ryan M Drenan
February 2018, Experimental and clinical psychopharmacology,
Noah B Walker, and Brenton R Tucker, and Leanne N Thomas, and Andrew E Tapp, and Anna I Neel, and Rong Chen, and Sara R Jones, and Ryan M Drenan
May 1998, Psychopharmacology,
Noah B Walker, and Brenton R Tucker, and Leanne N Thomas, and Andrew E Tapp, and Anna I Neel, and Rong Chen, and Sara R Jones, and Ryan M Drenan
June 2010, Hormones and behavior,
Noah B Walker, and Brenton R Tucker, and Leanne N Thomas, and Andrew E Tapp, and Anna I Neel, and Rong Chen, and Sara R Jones, and Ryan M Drenan
May 2006, Experimental and clinical psychopharmacology,
Noah B Walker, and Brenton R Tucker, and Leanne N Thomas, and Andrew E Tapp, and Anna I Neel, and Rong Chen, and Sara R Jones, and Ryan M Drenan
January 1988, Life sciences,
Noah B Walker, and Brenton R Tucker, and Leanne N Thomas, and Andrew E Tapp, and Anna I Neel, and Rong Chen, and Sara R Jones, and Ryan M Drenan
November 2005, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Noah B Walker, and Brenton R Tucker, and Leanne N Thomas, and Andrew E Tapp, and Anna I Neel, and Rong Chen, and Sara R Jones, and Ryan M Drenan
December 1991, Pharmacology, biochemistry, and behavior,
Noah B Walker, and Brenton R Tucker, and Leanne N Thomas, and Andrew E Tapp, and Anna I Neel, and Rong Chen, and Sara R Jones, and Ryan M Drenan
February 2021, Behavioural pharmacology,
Copied contents to your clipboard!